Efficacy and safety of immune checkpoint inhibitors in advanced or recurrent endometrial cancer: individual patient data and trial-level meta-analysis

Objective Whether immune checkpoint inhibitor (ICI)-based regimens confer a survival benefit over chemotherapy (CT) alone in advanced/recurrent endometrial cancer (EC), particularly by mismatch repair status, remains inconclusive. We conducted an individual patient data (IPD) meta-analysis of randomized trials comparing ICI-based regimens vs. CT alone to quantify survival benefits and assess safety.

Authors

Institutions

Publication Details

Journal
Journal of Gynecologic Oncology
Published
2026-11-18
DOI
https://doi.org/10.3802/jgo.2027.38.e46
Primary Topic
Endometrial and Cervical Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Efficacy and safety of immune checkpoint inhibitors in advanced or recurrent endometrial cancer: individual patient data and trial-level meta-analysis

Fengping Shao, Yanchun Liang
1 links
Journal of Gynecologic Oncology
Endometrial and Cervical Cancer Treatments
article

Efficacy and safety of immune checkpoint inhibitors in advanced or recurrent endometrial cancer: individual patient data and trial-level meta-analysis

Fengping Shao, Yanchun Liang
article en

Abstract

Objective Whether immune checkpoint inhibitor (ICI)-based regimens confer a survival benefit over chemotherapy (CT) alone in advanced/recurrent endometrial cancer (EC), particularly by mismatch repair status, remains inconclusive. We conducted an individual patient data (IPD) meta-analysis of randomized trials comparing ICI-based regimens vs. CT alone to quantify survival benefits and assess safety.

Journal of Gynecologic OncologyVol. 38
The First Affiliated Hospital, Sun Yat-sen University (CN), Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University (CN)
Natural Science Foundation of Guangdong Province, National Key Research and Development Program of China
Good health and well-being
Endometrial and Cervical Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon